This study is currently not recruiting participants.

A Randomized Open-Label Phase 2 Study of EC145 Single-Agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants with Folate-Receptors Positive [FR(++)] Second Line NSCLC

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The purpose of this study is to test the effects of EC145 , an experimental drug, given alone or in combination with docetaxel in men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) that has progressed or recurred (came b

Description

The purpose of this study is to test the effects of EC145 , an experimental drug, given alone or in combination with docetaxel in men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) that has progressed or recurred (came b

Details
Condition Lung Cancer
Age 18years - 100years
Clinical Study IdentifierTX2814
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.